AstraZeneca sketches plans for a $1B venture fund — and it’s going to China
Looking to the world’s second largest healthcare market, AstraZeneca is helping set up a life sciences venture fund to groom Chinese startups that could turn into potential partners.
CEO Pascal Soriot aims to raise $1B over the next four years. The short-term goal for this year is to raise $200M to $300M, and firms such as Sequoia Capital and Temasek have already expressed interest.
